Literature DB >> 33729496

AMH Highly Correlates with Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve Independent of Age.

Reshef Tal1, David B Seifer1, Renana Tal2, Emily Granger2, Ethan Wantman3, Oded Tal4.   

Abstract

CONTEXT: Antimullerian hormone (AMH) level is strongly associated with ovarian response in reproductive technology (ART) cycles but is a poor predictor of live birth. It is unknown whether AMH is associated with cumulative live birth rates (CLBR) in women with diminished ovarian reserve (DOR).
OBJECTIVE: To examine the association between serum AMH and CLBR among women with DOR undergoing ART.
DESIGN: Retrospective analysis of Society for Assisted Reproductive Technology Clinic Outcome Reporting System database 2014-16.
SETTING: Not applicable. PATIENTS: A total of 34,540 index retrieval cycles of women with AMH<1 ng/ml.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Cumulative live birth.
RESULTS: A total of 34,540 (25.9%) cycles with AMH<1 ng/ml out of 133,442 autologous index retrieval cycles were analyzed. Cycles with preimplantation genetic testing or egg/embryo banking were excluded. Data was stratified according to AMH and age and regression analysis of AMH and CLBR was performed for each age strata. Multiple logistic regression demonstrated that AMH is an independent predictor of CLBR (Odds ratio 1.39, 95%CI 1.18-1.64). Serum AMH was strongly associated with number of oocytes retrieved, embryos cryopreserved, mean number of cumulative embryos transferred, and percentage of cycles that had an embryo transfer,. Linear regression analysis demonstrated that AMH highly correlated with CLBR in each age strata.
CONCLUSIONS: Serum AMH is highly correlated with CLBR in women with DOR independent of age. The addition of AMH to current age-based prognostication counseling particularly in women with DOR would provide more informative and personalized CLBR prediction prior to ART.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Antimullerian hormone (AMH); Assisted Reproductive Technologies (ART); Cumulative live birth rate; Diminished ovarian reserve (DOR); SARTCORS

Year:  2021        PMID: 33729496     DOI: 10.1210/clinem/dgab168

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  The interplay between diabetes mellitus and menopause: clinical implications.

Authors:  Irene Lambrinoudaki; Stavroula A Paschou; Eleni Armeni; Dimitrios G Goulis
Journal:  Nat Rev Endocrinol       Date:  2022-07-07       Impact factor: 47.564

2.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin Signaling.

Authors:  Tian Gao; Yi Cao; Min Hu; Ying Du
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

3.  Which Factors Are Associated With Reproductive Outcomes of DOR Patients in ART Cycles: An Eight-Year Retrospective Study.

Authors:  Lu Li; Bo Sun; Fang Wang; Yile Zhang; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

4.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

5.  Is ovarian reserve reduction following endometriotic cystectomy predicted? The implication for fertility preservation counseling.

Authors:  Johnny S Younis; Nora Shapso; Ido Izhaki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

Review 6.  Challenges in Measuring AMH in the Clinical Setting.

Authors:  Hang Wun Raymond Li; David Mark Robertson; Chris Burns; William Leigh Ledger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.